Abstract:Lung adenocarcinoma (LUAD) is the most common histological subtype of the deadliest cancer in the United States. This cancer can arise from a high rate of mutations exaggerated by dysregulation in DNA damage and repair signaling that cause genomic instability. LUAD has largely been studied in the context of protein-coding genes, however, recent studies have implicated long noncoding RNAs (lncRNAs) as critical regulators of gene expression in the DNA damage response, controlling the repair mechanism response's magnitude, duration, and resolution. My lab has identified the lncRNA LINC00261 as a tumor suppressor in LUAD that regulates the activation of the DNA damage repair system; however, its exact mechanisms of action remain unknown. We found that the reintroduction of LINC00261 in LUAD is associated with G2/M cell cycle arrest and phosphorylation-mediated activation of key DNA damage response pathway components. We hypothesize that LINC00261 protects DNA fidelity through direct interaction with repair components and aim to obtain insights into the essential functions that LINC00261 plays in the DNA damage response. We observe that LINC00261 is differentially highly expressed upon increased DNA damage with UV-light and ionizing radiation alongside enhanced expression of DDR components like p53. We have conducted initial RNA-FISH and ChIRP-MS studies to characterize the molecular mechanisms of this lncRNA. We demonstrate that subcellular localization of LINC00261 is found to be distributed in both the cytoplasm and nucleus, inferring an ability to function in cis and in trans to interact with partners locally and genome wide. Initial ChIRP mass spectrometry pilot data shows significant enrichment for DNA replication and p53 pathway activity. These findings contribute valuable information to understanding the role of LINC00261 in the DNA damage response and have implications for how lncRNA-mediated dysregulation of DNA repair leads to genomic instability and oncogenic activation. Citation Format: Michele Ramos Correa, Jonathan Castillo, Crystal N. Marconett. Identifying the binding partners of a long noncoding RNA involved in the DNA damage response [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: DNA Damage Repair: From Basic Science to Future Clinical Application; 2024 Jan 9-11; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2024;84(1 Suppl) nr A032.

LncRNA CTBP1-DT-encoded microprotein DDUP sustains DNA damage response signalling to trigger dual DNA repair mechanisms

The DDUP protein encoded by the DNA damage-induced CTBP1-DT lncRNA confers cisplatin resistance in ovarian cancer

Data from A20/TNFAIP3 Regulates the DNA Damage Response and Mediates Tumor Cell Resistance to DNA-Damaging Therapy

The E3 ubiquitin ligase DTX3L and the deubiquitinase USP28 fine-tune DNA double strand repair through mutual regulation of their protein levels

DNA damage response-related ncRNAs as regulators of therapy resistance in cancer

DDB2 Regulates DNA Replication Through PCNA-independent Degradation of CDT2

ER-associated degradation ligase HRD1 links ER stress to DNA damage repair by modulating the activity of DNA-PKcs

RUVBL1 ubiquitination by DTL promotes RUVBL1/2-β-catenin-mediated transcriptional regulation of NHEJ pathway and enhances radiation resistance in breast cancer

DOT1L-mediated RAP80 methylation promotes BRCA1 recruitment to elicit DNA repair

Suppression of DDX39B sensitizes ovarian cancer cells to DNA-damaging chemotherapeutic agents via destabilizing BRCA1 mRNA

DDX18 prevents R-loop-induced DNA damage and genome instability via PARP-1

DNA damage response in breast cancer and its significant role in guiding novel precise therapies

RPS15 Coordinates with CtIP to Facilitate Homologous Recombination and Confer Therapeutic Resistance in Breast Cancer

Genetic vulnerabilities upon inhibition of DNA damage response

FACS-based genome-wide CRISPR screens define key regulators of DNA damage signaling pathways

DNA damage-induced translocation of mitochondrial factor HIGD1A into the nucleus regulates homologous recombination and radio/chemo-sensitivity

Damage-induced lncRNAs control the DNA damage response through interaction with DDRNAs at individual double-strand breaks

Abstract A032: Identifying the binding partners of a long noncoding RNA involved in the DNA damage response

Micropeptide PACMP inhibition elicits synthetic lethal effects by decreasing CtIP and poly(ADP-ribosyl)ation

Computational identification of DNA damage-relevant lncRNAs for predicting therapeutic efficacy and clinical outcomes in cancer

Protein UFMylation regulates early events of ribosomal DNA double-stranded break response